Lipoma

1. Clinical Overview

Summary

A lipoma is a benign mesenchymal tumour composed of mature adipose tissue, representing the most common soft tissue neoplasm in adults with an estimated prevalence of 1-2% in the general population. [1,2] These tumours are characteristically slow-growing, painless, mobile, and soft ("doughy") subcutaneous masses enclosed within a thin fibrous capsule. [3]

While inherently benign, the critical clinical challenge lies in distinguishing lipomas from their malignant counterpart, liposarcoma (particularly atypical lipomatous tumour/well-differentiated liposarcoma), especially when lesions are large (> 5cm), deep to fascia, or exhibit atypical features. [4,5] The National Institute for Health and Care Excellence (NICE) guidelines mandate urgent imaging for any soft tissue mass exceeding 5cm or demonstrating concerning features to exclude sarcoma. [6]

Clinical Pearls

The "Slip Sign": A pathognomonic clinical examination finding. When gentle pressure is applied to the edge of a superficial lipoma, the tumour characteristically "slips" away from beneath the examining finger. This occurs because the encapsulated tumour is relatively mobile within the surrounding subcutaneous fat plane, unlike infiltrative lesions.

Lipoma vs Sebaceous (Epidermoid) Cyst: The two most common superficial lumps in clinical practice.

• Lipoma: Soft, mobile, slip sign positive, no punctum, not tethered to overlying skin, can "wobble" the skin over it.
• Epidermoid Cyst: Firm, tethered to skin (skin moves with the lump), punctum (central black dot) often visible, cannot move skin independently over the mass.

The "Golf Ball" Rule (5cm Rule): Any soft tissue mass that is > 5cm in maximum diameter (approximately the size of a golf ball) or deep to the investing fascia (cannot be mobilized freely) requires urgent ultrasound or MRI to exclude soft tissue sarcoma. [6] This represents a safety-critical referral threshold and should never be dismissed as "just a lipoma" without imaging confirmation.

Subfascial vs Subcutaneous: Subfascial (intramuscular) lipomas feel paradoxically firm when the underlying muscle contracts, as they become trapped and compressed by the fascia. This can mimic a solid tumour and mandates imaging to exclude malignancy. [7]

---

2. Epidemiology

Demographics

• Prevalence: Approximately 1-2% of the general population will develop at least one lipoma during their lifetime. [1,2] The true prevalence may be higher as many small asymptomatic lipomas go unreported.
• Age: Peak incidence occurs between 40-60 years of age. Lipomas are rare in children and adolescents; new lipomas in pediatric populations should prompt consideration of syndromic associations. [1]
• Gender: No significant gender predilection in sporadic cases, though certain variants show sex preferences (Dercum disease is predominantly female). [8]
• Body Habitus: No consistent association with obesity, though obese individuals may have higher detection rates.

Anatomical Distribution

• Common Sites:
  • "Trunk (back, shoulders): 40-50%"
  • "Neck and proximal upper extremities: 30-40%"
  • "Proximal lower extremities (thighs): 10-15%"
• Rare Sites:
  • "Hands and feet (distal extremities): less than 5%"
  • "Face: less than 5%"
  • Intraoral, intramuscular, and visceral locations are uncommon

Syndromic Associations

Multiple lipomas or lipomas in unusual distributions should prompt consideration of syndromic diagnoses:

• Familial Multiple Lipomatosis (FML): Autosomal dominant inheritance with high penetrance. Characterized by multiple symmetric lipomas typically affecting the trunk and proximal extremities, with relative sparing of the head and distal limbs. Onset typically in early adulthood. [9]

• Dercum Disease (Adiposis Dolorosa): Rare disorder characterized by multiple painful lipomas or diffuse adipose tissue deposits, occurring predominantly in obese postmenopausal women. Associated symptoms include chronic pain, fatigue, and psychological distress. Etiology remains unclear. [8]

• Gardner Syndrome: Autosomal dominant variant of familial adenomatous polyposis (FAP) caused by APC gene mutations. Classic triad includes:

  • Intestinal polyposis (100% risk of colorectal cancer if untreated)
  • Osteomas (skull, mandible)
  • Soft tissue tumours (lipomas, fibromas, epidermoid cysts) [10]

• Proteus Syndrome: Rare overgrowth syndrome characterized by disproportionate, progressive overgrowth of various tissues including lipomas, vascular malformations, and skeletal abnormalities.

• Bannayan-Riley-Ruvalcaba Syndrome: PTEN hamartoma syndrome featuring macrocephaly, lipomas, hemangiomas, and developmental delay.

---

3. Pathophysiology and Molecular Biology

Histological Characteristics

Lipomas are composed of mature adipocytes that are morphologically indistinguishable from normal fat cells under standard microscopy. [3] Key histological features include:

• Cellular Composition: Lobules of mature adipocytes with uniform cell size and peripheral nuclei
• Capsule: Thin fibrous capsule separating the tumour from surrounding tissues (critical feature distinguishing lipomas from normal adipose tissue)
• Vascularity: Minimal vasculature; predominantly thin-walled capillaries
• Stroma: Minimal fibrous stroma between adipocyte lobules

Molecular Genetics

Recent advances in molecular cytogenetics have revealed that lipomas are clonal neoplasms with recurrent chromosomal abnormalities, challenging the historical view of lipomas as purely hyperplastic lesions. [11]

Common Cytogenetic Alterations:

• 12q13-15 rearrangements (20-30% of cases): Involving HMGA2 gene
• 6p21-23 rearrangements (10-15%): Involving HMGA1 gene
• 13q rearrangements (5-10%)
• Normal karyotype (40-50%): Suggesting heterogeneous pathogenesis

HMGA Gene Family: High-mobility group AT-hook (HMGA) genes encode chromatin-binding proteins that regulate gene transcription. Rearrangements lead to overexpression, promoting adipocyte proliferation and tumour formation.

Histological Variants

---

4. Clinical Presentation

Symptoms

The classic presentation is a patient in their 40s-60s reporting:

• Chief Complaint: "I've noticed a lump" or "It's been there for years"
• Duration: Typically months to years; very slow growth is characteristic
• Pain: Usually painless
  • "Pain suggests: angiolipoma, nerve compression, rapid growth (concerning for malignancy), or trauma"
• Growth Pattern: Imperceptibly slow; stable size over years is typical
  • "Red Flag: Growth > 1cm per month or recent accelerated growth suggests malignancy"
• Functional Impact: Usually none; large lipomas may cause pressure symptoms, cosmetic concerns, or mechanical interference with clothing/activities

Sites and Distribution Patterns

Common Presentations:

• Solitary subcutaneous lipoma: Most common (90%); trunk or proximal extremities
• Multiple lipomas: Consider familial syndrome if:

  • 10 lipomas

  • Symmetric distribution
  • Family history
  • Young age of onset (less than 30 years)

Rare but Important Locations:

• Subfascial/Intramuscular: Thigh most common; feel firm when muscle contracts
• Intermuscular: Between muscle planes; may cause nerve compression
• Parosteal: Adjacent to bone periosteum
• Intraosseous: Within bone (calcaneus most common)
• Visceral: GI tract, mediastinum, retroperitoneum (often incidental findings)

---

5. Clinical Examination

Systematic Approach to Soft Tissue Lumps

Inspection:

• Size: Measure maximum diameter with ruler/tape
• Shape: Lipomas typically have smooth, lobulated contours
• Overlying Skin: Normal (vs tethered, inflamed, ulcerated, punctum)
• Relationship to Surrounding Structures: Does it move with muscle contraction?

Palpation:

• Consistency: Soft, "doughy," compressible (pathognomonic for lipoma)
  • "Firm → consider: cyst, fibroma, sarcoma"
  • "Hard → consider: malignancy, calcification, bone"
• Mobility:
  • "Horizontal Mobility: Can move side-to-side in subcutaneous plane"
  • Vertical Mobility: Can "tent" skin over it
  • "Slip Sign: Characteristic slipping sensation when edge is compressed"
• Skin Attachment:
  • "Lipoma: NOT attached; skin moves freely over mass"
  • "Epidermoid cyst: Tethered; skin moves with mass"
• Temperature: Should be same as surrounding tissue
  • Warmth suggests inflammation or high metabolic activity (concerning for sarcoma)
• Tenderness: Should be non-tender
  • Painful → angiolipoma, nerve compression, or malignancy

Special Tests:

• Transillumination: Usually negative (unlike cystic lesions)
• Muscle Contraction: If over muscle, does it become firm or fixed? (suggests subfascial location)

Red Flag Features Mandating Urgent Referral [6]

---

6. Differential Diagnosis

Primary Differentials for Subcutaneous Lumps

Lipoma vs Atypical Lipomatous Tumour/Well-Differentiated Liposarcoma (ATL/WDL)

This distinction is critical as it fundamentally changes management from simple excision to oncological wide excision. [4,5]

Clinical Clues Favoring ATL/WDL:

• Size > 10cm (though 5cm is referral threshold)
• Deep (subfascial) location
• Thigh > trunk > retroperitoneum locations
• Age > 50 years
• Male sex

Imaging Features:

• MRI: Thick septa (> 2mm), nodular/solid components, heterogeneous enhancement
• Ultrasound: Heterogeneous echotexture, internal vascularity on Doppler

Diagnostic Scoring Systems: Recent research has developed multiparametric scoring systems combining clinical, radiological, and histological features to improve preoperative differentiation. [12] These include assessment of:

• Age and sex
• Tumour size and depth
• Imaging characteristics (septal thickness, nodularity)
• Vascular flow on Doppler

Definitive Diagnosis:

• MDM2 and CDK4 Immunohistochemistry: Positive in > 90% of ATL/WDL; negative in lipomas [5]
• FISH for MDM2 amplification: Gold standard molecular test
• D-dimer levels: Some studies suggest elevated D-dimer may favor liposarcoma, though not widely adopted [13]

---

7. Investigations

Imaging Modalities

Ultrasound (First-Line for > 5cm or Uncertain Lesions)

Indications:

• Any soft tissue mass > 5cm
• Atypical features on examination
• Deep or fixed lesions
• Uncertainty in clinical diagnosis

Typical Lipoma Findings [14]:

• Echogenicity: Hyperechoic or isoechoic relative to subcutaneous fat
• Architecture: Homogeneous, well-defined margins
• Compressibility: Easily compressed with probe pressure
• Vascularity: Minimal or absent flow on color Doppler
• Acoustic Enhancement: None (solid lesion)

Features Concerning for Malignancy:

• Heterogeneous echotexture
• Internal vascularity on Doppler
• Thick septa or nodular components
• Deep fascial invasion
• Associated lymphadenopathy

Advantages: Low cost, no radiation, readily available, real-time assessment Limitations: Operator-dependent, limited assessment of deep lesions, cannot definitively exclude malignancy

MRI (Gold Standard for Large, Deep, or Complex Lesions)

Indications:

• Size > 5cm with atypical ultrasound features
• Subfascial or intramuscular location
• Preoperative planning for complex lipomas
• Suspected liposarcoma

Lipoma MRI Protocol:

• T1-weighted images
• T2-weighted images
• Fat-suppression sequences (STIR or fat-sat)
• T1 post-contrast (if malignancy suspected)

Typical Lipoma MRI Findings:

• T1: Hyperintense (follows subcutaneous fat signal)
• T2: Hyperintense
• Fat-Suppression: Complete signal loss (confirms adipose tissue)
• Enhancement: None or minimal septal enhancement
• Margins: Well-defined, thin capsule

Features Suspicious for Liposarcoma [4]:

• Thick septa (> 2mm)
• Nodular or solid non-fat components
• Heterogeneous enhancement
• Infiltrative margins
• Adjacent bone invasion or muscle involvement

MRI Reporting Standards: The European Society of Musculoskeletal Radiology (ESSR) has established standardized reporting guidelines for soft tissue masses to improve diagnostic accuracy and treatment planning. [15]

CT Scan (Limited Role)

Indications:

• Visceral or retroperitoneal lipomas (incidental findings)
• Preoperative planning for deep/complex lesions if MRI unavailable

Typical Findings:

• Homogeneous fat attenuation (-50 to -150 Hounsfield units)
• Well-defined margins
• No enhancement

Limitations: Radiation exposure, inferior soft tissue contrast compared to MRI, difficult to distinguish lipoma from well-differentiated liposarcoma

Biopsy and Tissue Diagnosis

Critical Safety Principle: Do NOT perform excisional biopsy or random core biopsy of a suspected sarcoma in primary care or general surgical settings. [6,16]

Rationale:

• Biopsy tract can seed tumour cells
• The biopsy tract must be excised en bloc with the tumour during definitive resection
• Inappropriate biopsy can compromise oncological outcomes and limb salvage options
• Requires specialist sarcoma MDT planning

Appropriate Pathway for Suspected Sarcoma:

1. Urgent MRI
2. Referral to specialist sarcoma centre
3. MDT discussion
4. Image-guided core biopsy with planned tract orientation (if needed)
5. Definitive surgical plan based on histology

When Biopsy IS Appropriate:

• Image-guided core biopsy for lesions suspicious on MRI, performed by sarcoma centre
• Excision biopsy for small (less than 2cm), superficial, clinically-clear lipomas (diagnostic and therapeutic)

Histological Confirmation: For excised lipomas, histopathology confirms:

• Mature adipose tissue
• Thin fibrous capsule
• Absence of lipoblasts or atypical cells
• MDM2/CDK4 immunohistochemistry if any concern for ATL/WDL

---

8. Management

Management Algorithm

               SOFT TISSUE LUMP
                      ↓
         ┌────────────┴───────────┐
         │  CLINICAL EXAMINATION  │
         └────────────┬───────────┘
                      ↓
         RED FLAGS PRESENT?
       (> 5cm, Deep, Rapid Growth,
        Pain, Fixed, Heterogeneous)
         ┌────────┴────────┐
        YES                NO
         ↓                 ↓
    URGENT IMAGING    CLINICAL Dx
    (US or MRI)       (Lipoma)
    (2WW Referral)         ↓
         ↓            SYMPTOMATIC?
    CONFIRMED?        ┌─────┴─────┐
    ┌────┴────┐      YES          NO
  LIPOMA   SARCOMA    ↓           ↓
    ↓         ↓     EXCISION   OBSERVATION
  Large?   SARCOMA   Under LA   Reassure
    ↓      MDT       (less than 5cm)    Safety-net
  > 5cm?              Send        Advice
    ↓                Histology
  Consider            ↓
  Oncology    Confirm Benign
  Excision

Conservative Management (Observation)

Indications:

• Small (less than 5cm), asymptomatic, clinically-typical lipomas
• Patient preference after informed discussion
• Significant comorbidities precluding surgery
• Multiple lipomas where excision of all lesions is impractical

Patient Counseling:

• Lipomas are benign and do not require removal unless symptomatic
• Malignant transformation is exceedingly rare
• Growth is typically very slow
• Return if: rapid growth, pain develops, or functional impairment

Safety-Netting:

• Provide written information on red flag symptoms
• "Return if it grows quickly or becomes painful"
• Document counseling in medical records

Follow-Up: Not routinely required for stable, asymptomatic lipomas

Surgical Excision

Indications:

• Absolute: Diagnostic uncertainty, features concerning for malignancy
• Relative:
  • Patient-reported symptoms (cosmesis, discomfort, anxiety)
  • Pressure symptoms (nerve compression, mechanical interference)
  • Functional impairment
  • Rapid growth or change in character

Important Note on NHS Funding: In the UK National Health Service and many other healthcare systems, lipoma excision is often classified as a "Procedure of Low Clinical Priority" (PLCP) or "Procedure of Limited Clinical Value" (PLCV) when performed solely for cosmetic reasons. Funding may require Individual Funding Request (IFR) demonstrating functional or psychological impact. [17]

Surgical Technique: Standard Excision

Preoperative Planning:

• Mark lesion with patient seated/standing (lipomas can shift when supine)
• Plan incision along relaxed skin tension lines (RSTL) where possible
• Obtain informed consent including risks: bleeding, infection, nerve injury, recurrence, scar

Procedure (for superficial subcutaneous lipoma less than 5cm):

1. Anesthesia: Local anesthetic (1% lidocaine with epinephrine) infiltrated around capsule

   • Large lipomas may require tumescent technique or general anesthesia

2. Incision:

   • Length typically 1/2 to 2/3 of tumour diameter
   • Directly over center of mass
   • Through skin and subcutaneous fat to capsule

3. Dissection:

   • Identify glistening white capsule
   • Blunt dissection using fingers, gauze, or closed scissors
   • "Shell out" the lipoma with capsule intact (enucleation)
   • Lipoma typically separates easily from surrounding tissue (except intramuscular variants)

4. Hemostasis:

   • Bipolar diathermy to small vessels
   • Check for bleeding with release of tourniquet effect

5. Closure:

   • Consider dead space obliteration with deep absorbable sutures (if large cavity)
   • Subcuticular closure for cosmesis
   • Adhesive strips or tissue glue to skin edges

6. Specimen:

   • Send ALL excised tissue for histopathology
   • Label with patient details and anatomical site

Postoperative Care:

• Pressure dressing for 24-48 hours
• Avoid strenuous activity for 1-2 weeks
• Suture removal at 7-14 days (if non-absorbable used)
• Histopathology review at follow-up

Recurrence Rate: less than 5% if capsule completely excised [18]; higher for intramuscular lipomas

Alternative/Adjunct Techniques

Liposuction-Assisted Excision:

• Technique: Aspirate lipoma contents via small incisions, then remove capsule
• Advantages: Smaller incisions, reduced scarring, faster recovery
• Disadvantages: Higher recurrence (10-20%) as capsule may be incomplete, difficult to send adequate tissue for histology
• Indications: Large lipomas where cosmesis is paramount and diagnosis is certain

Minimal Excision Techniques:

• Squeeze technique through small incision
• Useful for small, mobile, superficial lipomas with certain diagnosis
• Recurrence rate higher than standard excision

Endoscopic Excision:

• For selected deep or large lipomas in cosmetically-sensitive areas
• Requires specialized equipment and expertise

Management of Special Scenarios

Multiple Lipomas:

• Prioritize symptomatic lesions
• Staged excisions to minimize surgical burden
• Genetic counseling if syndromic pattern

Intramuscular Lipomas:

• Higher recurrence rate due to infiltrative margins [7]
• May require wide excision with muscle fiber sacrifice
• MRI essential for preoperative planning

Giant Lipomas (> 10cm):

• Often require general anesthesia
• Consider plastic surgery referral for complex closure or reconstruction
• Ensure sarcoma excluded with MRI prior to surgery

Lipomas in Special Locations:

• Neck: Proximity to neurovascular structures; consider specialist referral
• Axilla: Risk to brachial plexus; careful dissection required
• Groin: Proximity to femoral vessels and nerve
• Periorbital: Ophthalmology or oculoplastic referral

---

9. Complications

Complications of the Lipoma Itself

Nerve Compression:

• Large or strategically-located lipomas can compress peripheral nerves
• Examples: Radial nerve (spiral groove), median nerve (carpal tunnel), sciatic nerve
• Presentation: Paresthesias, weakness, pain in nerve distribution
• Management: Surgical excision with nerve decompression

Vascular Compression:

• Rare; typically only with very large deep lipomas
• Can cause venous congestion or arterial insufficiency

Cosmetic Disfigurement:

• Large visible lipomas causing distress or social anxiety
• Psychological impact may warrant excision even if physically asymptomatic

Mechanical Interference:

• Interferes with clothing (belt line, bra strap)
• Affects athletic performance or occupational activities
• Painful friction or trauma to lipoma

Bowel Obstruction:

• Exceptionally rare; case reports of large intra-abdominal lipomas causing obstruction

Complications of Surgical Excision

Immediate:

• Bleeding/Hematoma: (1-3%) - Managed with pressure, drainage if large
• Seroma: (2-5%) - Fluid collection; prevented with pressure dressings; aspirate if symptomatic
• Infection: (less than 1%) - Rare; treat with antibiotics ± drainage

Early:

• Wound Dehiscence: Poor healing; requires re-suturing or healing by secondary intention
• Nerve Injury: Damage to cutaneous or motor nerves during dissection (1-2%)

Late:

• Recurrence: less than 5% for simple lipomas with complete capsule excision; 10-20% for intramuscular or incompletely excised lipomas [18]
• Scar: Hypertrophic scar, keloid (predisposed individuals), or unsatisfactory cosmesis
• Numbness: Permanent cutaneous nerve damage causing altered sensation

Malignant Change

Critical Point: Benign lipomas do NOT undergo malignant transformation into liposarcomas. [2,4]

• Liposarcomas arise de novo from primitive mesenchymal cells
• The coexistence of "lipoma" and liposarcoma represents either:
  • Misdiagnosis (lesion was always ATL/WDL)
  • Coincidental occurrence (extremely rare)
• Well-differentiated liposarcoma can dedifferentiate (5% risk) into higher-grade sarcoma

Clinical Implication: A stable lipoma that suddenly changes character (rapid growth, pain, firmness) should be re-evaluated for diagnostic accuracy, not "transformation."

---

10. Prognosis and Outcomes

Natural History

• Benign Course: Simple lipomas remain benign indefinitely
• Growth Pattern: Slow growth over years; may stabilize in size
• Regression: Rare; lipomas generally do not spontaneously resolve
• Lifespan Impact: No impact on life expectancy

Surgical Outcomes

Recurrence Rates [18]:

• Simple subcutaneous lipoma with complete excision: less than 5%
• Intramuscular lipoma: 10-25% (higher due to infiltrative nature)
• Liposuction or incomplete excision: 10-20%
• Time to recurrence: Typically 1-3 years if occurs

Factors Associated with Recurrence:

• Incomplete capsule excision
• Intramuscular or infiltrative growth pattern
• Liposuction technique (capsule left behind)
• Multiple lipomas (suggests ongoing genetic propensity)

Cosmetic Outcomes:

• Generally excellent with appropriate technique
• Scarring proportional to incision size
• Patient satisfaction high when expectations managed appropriately

Malignancy Risk:

• Zero risk of transformation in true lipoma
• Importance of correct initial diagnosis cannot be overstated

---

11. Evidence and Guidelines

Key Guidelines

Landmark Evidence

1. The Rationale for the 5cm Threshold

Study: Dangoor A, et al. UK guidelines for the management of soft tissue sarcomas. Clin Sarcoma Res. 2016. [16]

Key Findings:

• Lesions > 5cm have significantly higher risk of being sarcoma vs benign
• Size is the single most important clinical predictor
• Deep location (subfascial) is second most important predictor
• Combined size + depth criteria capture > 95% of soft tissue sarcomas

Clinical Application: The "golf ball rule" is evidence-based and should be strictly applied

2. Diagnostic Accuracy of MDM2/CDK4 in Lipoma vs Liposarcoma

Study: Asano Y, et al. Scoring system combining clinical, radiological, and histopathological examinations for differential diagnosis. Sci Rep. 2022. [12]

Key Findings:

• MDM2 amplification sensitivity > 90%, specificity > 95% for ATL/WDL
• Combined scoring using age, size, location, imaging, and MDM2 improved preoperative diagnosis
• D-dimer levels showed promise but require validation

Clinical Application: Immunohistochemistry for MDM2/CDK4 should be routine for any lipomatous tumour with atypical features

3. Recurrence After Surgical Excision

Study: Su CH, et al. Surgical treatment of intramuscular, infiltrating lipoma. Int Surg. 2011. [7]

Key Findings:

• Intramuscular lipomas have 19% recurrence rate vs 3% for subcutaneous
• Incomplete excision is primary risk factor
• Wide excision with margins reduces recurrence but increases morbidity

Clinical Application: Intramuscular lipomas require careful counseling regarding higher recurrence risk

---

12. Patient and Layperson Explanation

What is a Lipoma?

A lipoma is a harmless "fatty lump" that grows under your skin. It is made of the same fat cells as the rest of your body fat, but these cells have grown together inside a thin bag-like covering (capsule). This is why it feels like a soft lump.

How Common Are They?

Very common. About 1 in 100 people will get at least one lipoma at some point in their life. They usually appear in middle age (40s-60s).

Is it Cancer?

No. A lipoma is not cancer. It is a benign (non-cancerous) growth. It does not spread to other parts of your body.

Will it Turn Into Cancer?

No. Lipomas do not turn into cancer. There is a different type of fatty lump called a liposarcoma which IS cancer, but this develops separately—lipomas do not change into liposarcomas.

Why Did I Get a Lipoma?

We don't fully understand why people get lipomas. In some cases they run in families. They are not caused by your diet, how much you exercise, or anything you did wrong.

Do I Need It Removed?

Most lipomas do NOT need to be removed. It is perfectly safe to leave it alone if it doesn't bother you.

Reasons you might want it removed:

• It looks unsightly and affects your confidence
• It rubs on your clothes or gets in the way
• It is growing or becoming painful (though this needs checking by a doctor)
• You are worried and would prefer it gone for peace of mind

Important: The NHS and many insurance companies will NOT fund removal purely for cosmetic reasons unless it is causing significant distress.

When Should I Worry?

You should see a doctor urgently if your lump:

• Is bigger than a golf ball (> 5cm)
• Is growing quickly
• Becomes painful
• Feels hard or firm (not soft and squishy)
• Is deep and difficult to move

These features may mean it is NOT a simple lipoma and needs investigating.

How is it Removed?

If you and your doctor decide to remove it, the procedure is usually very straightforward:

1. Local anesthetic: Numbing injection (like at the dentist)
2. Small cut: A cut in the skin over the lump
3. Pop it out: The lipoma usually comes out easily in one piece, like shelling a pea
4. Stitch it up: A few stitches to close the wound
5. Go home: Usually done as day-case; you go home the same day

Will It Come Back?

Rarely. If the whole lump including its capsule (covering) is removed, there is less than 1 in 20 chance (5%) it will grow back. If it does recur, it is usually because a tiny piece was left behind.

What Happens to the Lump?

All removed lumps are sent to a laboratory to be examined under a microscope. This confirms it was definitely a lipoma and not something else. Your doctor will discuss the results with you at a follow-up appointment.

---

13. Examination Focus (MRCS/FRCS/Clinical Exams)

Common OSCE/Clinical Exam Scenarios

Scenario 1: "Examine This Lump"

Key Steps:

1. Introduce, consent, expose, position (general comfort)
2. Inspection: Size, shape, overlying skin
3. Palpation: Soft, mobile, slip sign, no punctum
4. Special Features: Check for multiple lumps, café-au-lait spots (NF1), or other syndromic features

Expected Answer: "This is a soft, mobile, subcutaneous lump consistent with a lipoma. There is no punctum, the slip sign is positive, and there are no concerning features. I would reassure the patient and offer excision if symptomatic."

Examiner Question: "What would make you worried this is NOT a lipoma?" Answer: "Size > 5cm, deep/fixed, rapid growth, pain, firm consistency, or heterogeneous imaging features would concern me for soft tissue sarcoma, specifically atypical lipomatous tumour or liposarcoma."

---

Common Exam Questions and Model Answers

Q1: What is the 'Slip Sign'? A: When gentle pressure is applied to the edge of a subcutaneous lipoma, it characteristically slips away from beneath the examining finger due to its encapsulated mobile nature within the subcutaneous fat.

Q2: What is the differential diagnosis of a soft tissue lump? A:

• Benign: Lipoma, epidermoid cyst, fibroma, neurofibroma, ganglion, hemangioma
• Malignant: Liposarcoma, other soft tissue sarcomas
• Inflammatory: Abscess, organizing hematoma
• Other: Lymph node, hernia (if appropriate location)

Q3: How do you differentiate a lipoma from an epidermoid cyst? A:

Q4: What is the 'Golf Ball Rule' and what is its evidence base? A: Any soft tissue lump > 5cm (approximately golf ball size) or deep to fascia requires urgent ultrasound or MRI to exclude soft tissue sarcoma. This is based on NICE NG12 guidelines and UK sarcoma guidelines, which show that size > 5cm is the single most important predictor of malignancy in soft tissue masses. [6,16]

Q5: What syndromes are associated with multiple lipomas? A:

• Familial Multiple Lipomatosis: Autosomal dominant; multiple symmetric lipomas
• Dercum Disease: Multiple painful lipomas in obese postmenopausal women
• Gardner Syndrome: FAP + osteomas + soft tissue tumours (lipomas/cysts)
• Proteus Syndrome: Asymmetric overgrowth with lipomas and vascular malformations
• Bannayan-Riley-Ruvalcaba: PTEN mutation; macrocephaly, lipomas, hemangiomas

Q6: What is the molecular basis of lipomas? A: Lipomas are clonal neoplasms with recurrent chromosomal abnormalities, most commonly 12q13-15 rearrangements involving the HMGA2 gene (20-30%), 6p21-23 involving HMGA1 (10-15%), and 13q rearrangements (5-10%). These alterations lead to overexpression of chromatin-remodeling proteins that promote adipocyte proliferation. [11]

Q7: How do you distinguish lipoma from well-differentiated liposarcoma (atypical lipomatous tumour)? A:

Clinical: WDL typically > 10cm, deep (subfascial), thigh location, age > 50 Imaging (MRI): WDL shows thick septa (> 2mm), nodular components, heterogeneous enhancement Histology: WDL shows lipoblasts, nuclear atypia, and MDM2/CDK4 amplification (gold standard) [4,5,12]

Q8: Describe the surgical technique for lipoma excision. A:

1. Local anesthetic infiltration around capsule
2. Incision directly over lump (1/2 to 2/3 tumour diameter)
3. Identify and incise through subcutaneous fat to capsule
4. Blunt dissection to shell out encapsulated lipoma intact
5. Hemostasis
6. Consider dead space obliteration if large
7. Layered closure
8. Send all tissue for histopathology

Q9: What are the histological variants of lipoma? A:

• Conventional: Mature adipocytes only
• Angiolipoma: Excessive vasculature; often painful; young adults
• Spindle cell/Pleomorphic: Spindle cells, CD34+; mimics sarcoma; benign
• Hibernoma: Brown fat; hypermetabolic on PET
• Chondroid: Chondroid matrix; rare; mimics myxoid liposarcoma
• Intramuscular: Infiltrates muscle; higher recurrence

Q10: What is the recurrence rate after lipoma excision? A: less than 5% for simple subcutaneous lipomas with complete capsule excision. Higher recurrence (10-25%) for intramuscular lipomas due to infiltrative nature. Liposuction has 10-20% recurrence as capsule remains. [7,18]

---

Viva Points (Advanced Topics)

Hibernoma:

• Rare benign tumour of brown (multilocular) fat
• Locations: Interscapular, neck, mediastinum, retroperitoneum
• Imaging: May be FDG-avid on PET scan (mimics malignancy due to metabolically active brown fat)
• Histology: Multivacuolated adipocytes with granular eosinophilic cytoplasm
• Management: Excision if symptomatic; benign behavior

Liposarcoma Classification (WHO):

1. Well-Differentiated/Atypical Lipomatous Tumour: Most common (40-45%); excellent prognosis if completely excised; cannot metastasize but can locally recur; 5-10% risk of dedifferentiation
2. Dedifferentiated: WDL with high-grade sarcomatous component; worse prognosis; can metastasize
3. Myxoid/Round Cell: 30-35%; translocation t(12;16); better prognosis for pure myxoid
4. Pleomorphic: 5-10%; worst prognosis; high-grade from onset

Subfascial Lipoma:

• Lipoma located beneath deep investing fascia, within or between muscle compartments
• Clinical Pearl: Feels firm when muscle contracts (trapped by fascia), mimicking solid tumour
• Always requires MRI to exclude liposarcoma
• Higher recurrence after excision due to difficulty achieving complete capsule removal

Lipomatosis vs Lipoma:

• Lipoma: Encapsulated neoplasm
• Lipomatosis: Diffuse non-encapsulated overgrowth of adipose tissue (e.g., mediastinal lipomatosis in Cushing syndrome, pelvic lipomatosis)
• Lipomatosis is NOT a tumour; it is adipose hyperplasia

Parosteal Lipoma:

• Rare lipoma arising adjacent to bone periosteum
• May cause reactive bone changes (cortical erosion, hyperostosis, exostoses)
• Imaging essential to differentiate from bone tumour
• Benign; excision curative

---

14. Self-Assessment Questions

Question 1: A 52-year-old woman presents with a 7cm soft, mobile lump on her upper back present for "many years." On examination, the slip sign is positive and there is no tenderness. What is the MOST appropriate next step?

A) Reassure and discharge B) Arrange routine ultrasound C) Arrange urgent ultrasound D) Refer to dermatology E) Excisional biopsy in GP surgery

Answer: C - Any soft tissue lump > 5cm requires urgent imaging to exclude sarcoma, even if clinically consistent with lipoma (NICE NG12). [6]

---

Question 2: A 45-year-old man undergoes MRI for a 6cm thigh lump. The report describes "thick septa and nodular enhancement." Histology shows mature adipocytes with occasional lipoblasts. MDM2 immunohistochemistry is positive. What is the diagnosis?

A) Lipoma B) Angiolipoma C) Well-differentiated liposarcoma (atypical lipomatous tumour) D) Dedifferentiated liposarcoma E) Myxoid liposarcoma

Answer: C - Positive MDM2 is pathognomonic for well-differentiated liposarcoma/atypical lipomatous tumour. [5,12]

---

Question 3: Which of the following is TRUE regarding lipomas?

A) They have a 10-20% risk of malignant transformation B) They commonly occur in the hands and feet C) They are composed of immature adipocytes D) Complete excision has less than 5% recurrence rate E) They should always be excised to exclude malignancy

Answer: D - Complete excision of simple lipomas has less than 5% recurrence. Lipomas do NOT undergo malignant transformation, rarely occur in hands/feet, are composed of MATURE adipocytes, and do not always require excision. [18]

---

Medical Disclaimer: MedVellum content is for educational purposes and clinical reference. Clinical decisions should account for individual patient circumstances. Always consult appropriate specialists and follow local protocols and guidelines.

---

15. References

Primary Sources

1. Charifa A, Azmat CE, Badri T. Lipoma Pathology. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan. PMID: 29493968

2. Yee EJ, Stewart CL, Clay MR, et al. Lipoma and Its Doppelganger: The Atypical Lipomatous Tumor/Well-Differentiated Liposarcoma. Surg Clin North Am. 2022 Aug;102(4):557-572. doi: 10.1016/j.suc.2022.04.006. PMID: 35952693

3. Johnson CN, Ha AS, Chen E, Davidson D. Lipomatous Soft-tissue Tumors. J Am Acad Orthop Surg. 2018 Nov 15;26(22):779-788. doi: 10.5435/JAAOS-D-17-00045. PMID: 30192249

4. Sugiyama K, Washimi K, Sato S, et al. Differential diagnosis of lipoma and atypical lipomatous tumor/well-differentiated liposarcoma by cytological analysis. Diagn Cytopathol. 2022 Mar;50(3):134-141. doi: 10.1002/dc.24928. PMID: 34984861

5. Kammerer-Jacquet SF, Thierry S, Cabillic F, et al. Differential diagnosis of atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma: utility of p16 in combination with MDM2 and CDK4 immunohistochemistry. Hum Pathol. 2017 Jan;59:34-40. doi: 10.1016/j.humpath.2016.08.009. PMID: 27597521

6. National Institute for Health and Care Excellence. Suspected cancer: recognition and referral [NG12]. London: NICE; 2015 (updated 2021). Available from: https://www.nice.org.uk/guidance/ng12

7. Su CH, Hung JK, Chang IL. Surgical treatment of intramuscular, infiltrating lipoma. Int Surg. 2011 Jan-Mar;96(1):56-9. doi: 10.9738/cc75.1. PMID: 21675621

8. Campen R, Mankin H, Louis DN, Rosenberg AE. Familial occurrence of adiposis dolorosa (Dercum disease). J Am Acad Dermatol. 2001;44:132-6.

9. Schoenmakers EF, Wanschura S, Mols R, et al. Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours. Nat Genet. 1995;10:436-44.

10. Bussey HJ. Gastrointestinal polyposis. Gut. 1970 Nov;11(11):970-8. doi: 10.1136/gut.11.11.970. PMID: 4923739

11. Mitelman F, Johansson B, Mertens F. Fusion genes and rearranged genes as a linear function of chromosome aberrations in cancer. Nat Genet. 2004;36:331-4.

12. Asano Y, Miwa S, Yamamoto N, et al. A scoring system combining clinical, radiological, and histopathological examinations for differential diagnosis between lipoma and atypical lipomatous tumor/well-differentiated liposarcoma. Sci Rep. 2022 Jan 7;12(1):164. doi: 10.1038/s41598-021-04004-1. PMID: 34997060

13. Yoshiyama A, Morii T, Tajima T, et al. D-dimer levels in the differential diagnosis between lipoma and well-differentiated liposarcoma. Anticancer Res. 2014 Sep;34(9):5069-72. PMID: 25202112

14. Fornage BD, Tassin GB. Sonographic appearances of superficial soft tissue lipomas. J Clin Ultrasound. 1991;19:215-20.

15. Weiss S, Korthaus A, Baumann N, et al. Musculoskeletal Soft-Tissue Sarcoma: Quality Assessment of Initial MRI Reports Shows Frequent Deviation from ESSR Guidelines. Diagnostics (Basel). 2021 Apr 14;11(4):695. doi: 10.3390/diagnostics11040695. PMID: 33919690

16. Dangoor A, Seddon B, Gerrand C, et al. UK guidelines for the management of soft tissue sarcomas. Clin Sarcoma Res. 2016 Nov 15;6:20. doi: 10.1186/s13569-016-0060-4. PMID: 27891213

17. NHS England. Procedures of Limited Clinical Value. London: NHS England; 2019.

18. Salam GA. Lipoma excision. Am Fam Physician. 2002 Mar 1;65(5):901-4. PMID: 11898962

---

Document Statistics:

• Word Count: ~8,500 words
• Line Count: 798 lines
• Citation Count: 18 unique citations
• Last Updated: 2025-01-06